Law & Regulation
GOP Official In NY Wants Permission To Ban Public Weed Use & More Cannabis Updates
Lawmakers Praise FDA’s Move To Issue Guidance On Psychedelics Research
A bipartisan trio of lawmakers — Republicans Dan Crenshaw and Mariannette Miller-Meeks…
Lawmakers Praise FDA's Move To Issue Guidance On Psychedelics Research
- A bipartisan trio of lawmakers — Republicans Dan Crenshaw and Mariannette Miller-Meeks with Democrat Ro Khanna — applauded the FDA’s decision to issue its first guidance on psychedelics research.
- "I’m glad the FDA is taking this first step of issuing guidance for psychedelic clinical trials — and listening to my bipartisan legislation with Reps. Miller-Meeks and Khanna," Crenshaw said in a press release. "It’s critical we get this right for the researchers doing this important scientific work. We need this guidance to expand clinical trial access so that we can push towards life-saving psychedelic therapies for our veterans, service members, and people living with PTSD, traumatic brain injury, and substance abuse disorder."
- The FDA’s move comes on the heels of Crenshaw filing a measure that sought the issuance of such a document.
- “Many Veterans find guided use of psychedelics with assisted therapy as a way to successfully treat the excruciating, post-traumatic pain they face, with better outcomes and less medication side effects in pilot studies,” Miller-Meeks added. “As a physician, I know the importance of medical research, and I am encouraged by the FDA’s support and guidance regarding psychedelic clinical trials. This important ...
Full story available on Benzinga.com
fda research psychedelics psychedelic-
Psychedelics1 week ago
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Psychedelics1 week ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Law & Regulation1 week ago
Tryp Therapeutics merger with Exopharm approved by shareholders
-
Psilocybin1 week ago
Passover Perspectives: Psychedelics, Moses, and the Burning Bush
-
Psychedelics1 week ago
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Psilocybin1 week ago
Psilocybin and Meditation: Unlocking the Potential for Enhancing Insightfulness
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment